UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 4.360

Sortiert nach

Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin-Yang interplay between inflammation and cancer

Oncogene, 2010-06, Vol.29 (23), p.3313-3323

2010

Volltextzugriff (PDF)

Review article: the pathophysiology and medical management of diverticulosis and diverticular disease of the colon

Alimentary pharmacology & therapeutics, 2015-09, Vol.42 (6), p.664-684

2015

Volltextzugriff (PDF)

Role of the vascular and lymphatic endothelium in the pathogenesis of inflammatory bowel disease: ‘brothers in arms’

Gut, 2011-07, Vol.60 (7), p.998-1008

Danese, Silvio

2011

Volltextzugriff (PDF)

Systematic review with network meta‐analysis: comparative assessment of tofacitinib and biological therapies for moderate‐to‐severe ulcerative colitis

Alimentary pharmacology & therapeutics, 2018-02, Vol.47 (4), p.454-465

2018

Volltextzugriff (PDF)

Author response to: Covid‐19‐related pancreatic injury

British journal of surgery, 2020-06, Vol.107 (7), p.e191-e191

2020

Volltextzugriff (PDF)

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

Journal of Crohn's & colitis, 2010-02, Vol.4 (1), p.28-62

2010

Volltextzugriff (PDF)

Mechanisms of action of infliximab in inflammatory bowel disease: an anti-inflammatory multitasker

Digestive and liver disease, 2008-07, Vol.40, p.S225-S228

Danese, S

2008

Volltextzugriff (PDF)

Inflammatory Bowel Disease Management During the COVID-19 Outbreak: The Ten Do’s and Don’ts from the ECCO-COVID Taskforce

Journal of Crohn's and colitis, 2020-10, Vol.14 (Supplement_3), p.S798-S806

2020

Volltextzugriff (PDF)

Review article: optimal preparation for surgery in Crohn's disease

Alimentary pharmacology & therapeutics, 2014-11, Vol.40 (9), p.1009-1022

2014

Volltextzugriff (PDF)

Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target

The American journal of gastroenterology, 2015-09, Vol.110 (9), p.1324-1338

2015

Volltextzugriff (PDF)

Review article: causative factors and the clinical management of patients with Crohn’s disease who lose response to anti‐TNF‐α therapy

Alimentary pharmacology & therapeutics, 2011-07, Vol.34 (1), p.1-10

2011

Volltextzugriff (PDF)

Review article: infliximab for Crohn’s disease treatment – shifting therapeutic strategies after 10 years of clinical experience

Alimentary pharmacology & therapeutics, 2011-04, Vol.33 (8), p.857-869

2011

Volltextzugriff (PDF)

Systematic review with meta‐analysis: use of 5‐aminosalicylates and risk of colorectal neoplasia in patients with inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2017-05, Vol.45 (9), p.1179-1192

2017

Volltextzugriff (PDF)

IOIBD technical review on endoscopic indices for Crohn's disease clinical trials

Gut, 2016-09, Vol.65 (9), p.1447-1455

2016

Volltextzugriff (PDF)

Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn's disease

Inflammatory bowel diseases, 2011-05, Vol.17 (5), p.1073-1080

2011

Volltextzugriff (PDF)

Identification of serum and tissue micro‐RNA expression profiles in different stages of inflammatory bowel disease

Clinical and experimental immunology, 2013-08, Vol.173 (2), p.250-258

2013

Volltextzugriff (PDF)

Review article: the role of anti‐TNF in the management of ulcerative colitis – past, present and future

Alimentary Pharmacology & Therapeutics (Suppl), 2013-05, Vol.37 (9), p.855-866

2013

Volltextzugriff (PDF)

Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease

Gut, 2011-04, Vol.60 (4), p.463-472

2011

Volltextzugriff (PDF)

Colitis-associated cancer: the dark side of inflammatory bowel disease

Gut, 2011-12, Vol.60 (12), p.1609-1610

2011

Volltextzugriff (PDF)

Systematic review with network meta‐analysis: comparative efficacy and safety of budesonide and mesalazine (mesalamine) for Crohn's disease

Alimentary pharmacology & therapeutics, 2015-06, Vol.41 (11), p.1055-1065

2015

Volltextzugriff (PDF)

VP01.22: Cramp‐like abdominal pain: a light symptom, a big problem

Ultrasound in obstetrics & gynecology, 2021-10, Vol.58 (S1), p.95-95

2021

Volltextzugriff (PDF)

Review article: integrating budesonide‐MMX into treatment algorithms for mild‐to‐moderate ulcerative colitis

Alimentary pharmacology & therapeutics, 2014-05, Vol.39 (10), p.1095-1103

2014

Volltextzugriff (PDF)

Randomised clinical trial: mesalazine and/or probiotics in maintaining remission of symptomatic uncomplicated diverticular disease – a double‐blind, randomised, placebo‐controlled study

Alimentary pharmacology & therapeutics, 2013-10, Vol.38 (7), p.741-751

2013

Volltextzugriff (PDF)

Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients

Gut, 2003-10, Vol.52 (10), p.1435-1441

2003

Volltextzugriff (PDF)

Review article: anti TNF‐α induced psoriasis in patients with inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2009-05, Vol.29 (9), p.921-927

2009

Volltextzugriff (PDF)

1 – 25 von 4.360

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.331)
Mit Volltextzugriff
(3.708)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

IngentaConnect Journals
(2.072)
LWW Total
(1.442)
Elsevier ScienceDirect Journals Complete
(1.353)
MEDLINE
(1.326)
Free E-Journal (出版社公開部分のみ）
(1.208)
NUS Single-Journal Subscriptions
(930)
IngentaConnect Journals
(902)
EBSCOhost Business Source Ultimate
(735)
Wiley Online Library E-Journals
(579)
Oxford Journals
(568)
Oxford Journals 2020 Medicine
(454)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(235)
Wiley Online Library
(194)
Taylor & Francis
(194)
Taylor & Francis Journals Auto-Holdings Collection
(190)
Nature
(179)
Springer Journals
(177)
Taylor & Francis Journals Complete
(118)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(98)
BMJ
(80)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin-Yang interplay between inflammation and cancer

Review article: the pathophysiology and medical management of diverticulosis and diverticular disease of the colon

Role of the vascular and lymphatic endothelium in the pathogenesis of inflammatory bowel disease: ‘brothers in arms’

Systematic review with network meta‐analysis: comparative assessment of tofacitinib and biological therapies for moderate‐to‐severe ulcerative colitis

Author response to: Covid‐19‐related pancreatic injury

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

Mechanisms of action of infliximab in inflammatory bowel disease: an anti-inflammatory multitasker

Inflammatory Bowel Disease Management During the COVID-19 Outbreak: The Ten Do’s and Don’ts from the ECCO-COVID Taskforce

Review article: optimal preparation for surgery in Crohn's disease

Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target

Review article: causative factors and the clinical management of patients with Crohn’s disease who lose response to anti‐TNF‐α therapy

Review article: infliximab for Crohn’s disease treatment – shifting therapeutic strategies after 10 years of clinical experience

Systematic review with meta‐analysis: use of 5‐aminosalicylates and risk of colorectal neoplasia in patients with inflammatory bowel disease

IOIBD technical review on endoscopic indices for Crohn's disease clinical trials

Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn's disease

Identification of serum and tissue micro‐RNA expression profiles in different stages of inflammatory bowel disease

Review article: the role of anti‐TNF in the management of ulcerative colitis – past, present and future

Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease

Colitis-associated cancer: the dark side of inflammatory bowel disease

Systematic review with network meta‐analysis: comparative efficacy and safety of budesonide and mesalazine (mesalamine) for Crohn's disease

VP01.22: Cramp‐like abdominal pain: a light symptom, a big problem

Review article: integrating budesonide‐MMX into treatment algorithms for mild‐to‐moderate ulcerative colitis

Randomised clinical trial: mesalazine and/or probiotics in maintaining remission of symptomatic uncomplicated diverticular disease – a double‐blind, randomised, placebo‐controlled study

Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients

Review article: anti TNF‐α induced psoriasis in patients with inflammatory bowel disease

Suchergebnisse filtern